Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
Product: Active Ingredients:
Dosage Form: New Zealand Sponsor: Manufacturer:
|
Plasma-Lyte 148, pH 7.4 Magnesium chloride hexahydrate 0.3g/L Potassium chloride 0.37g/L Sodium acetate trihydrate 3.68g/L Sodium chloride 5.26g/L Sodium gluconate 5.02g/L Solution for infusion Baxter Healthcare Limited Baxter Healthcare Pty Limited, Sydney, Australia
|
Product: Active Ingredients:
Dosage Form: New Zealand Sponsor: Manufacturer:
|
Potassium 40mmol and 0.9% Sodium Chloride Potassium chloride 29.8g/L Sodium chloride 9g/L Solution for infusion Baxter Healthcare Limited Baxter Healthcare Pty Limited, Sydney, Australia
|
Product:
Active Ingredients:
Dosage Form: New Zealand Sponsor: Manufacturer:
|
Potassium Chloride 20mmol in 4% Glucose and 0.18% Sodium Chloride Glucose 40g/L Potassium chloride 1.5g/L Sodium chloride 1.8g/L Solution for infusion Baxter Healthcare Limited Baxter Healthcare Pty Limited, Sydney, Australia
|
Product:
Active Ingredients:
Dosage Form: New Zealand Sponsor: Manufacturer:
|
Potassium Chloride 30mmol in 4% Glucose and 0.18% Sodium Chloride (Baxter) Glucose 40g/L Potassium chloride 2.24g/L Sodium chloride 1.8g/L Solution for infusion Baxter Healthcare Limited Baxter Healthcare Pty Limited, Sydney, Australia
|
Product: Active Ingredients: Dosage Form: New Zealand Sponsor: Manufacturers:
|
Tygacil Tigecycline 50mg Powder for infusion Pfizer New Zealand Limited Patheon Italia SpA, Milan, Italy Wyeth Lederle SrL, Catania, Italy
|
Dated this 17th day of February 2017.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).